Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CLASS III ANTIARRHYTHMIC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 104 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Oshikawa, N; Watanabe, I; Masaki, R; Shindo, A; Kojima, T; Saito, S; Ozawa, Y; Kanmatsuse, K
      Frequency-dependent electrophysiological effect of ibutilide on human atrium and ventricle

      JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
    2. Restivo, M; Hegazy, M; El-Hamami, M; Yin, H; Caref, EB; Assadi, MA; Brooks, RR; El-Sherif, N
      Efficacy of azimilide and dofetilide in the dog right atrial enlargement model of atrial flutter

      JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    3. Himmel, HM; Wettwer, E; Lues, I; Beier, N; Jonas, R; Ravens, U
      Three thiadiazinone derivatives, EMD 60417, EMD 66430, and EMD 66398, withclass III antiarrhythmic activity but different electrophysiologic profiles

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    4. Pickoff, AS; Stolfi, A
      Comparison of the rate dependent effects of dofetilide and ibutilide in the newborn heart

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    5. Brooks, RR; Pong, SF; Izzo, NJ; Moorehead, TJ; Gopalakrishnan, M; Triggle, DJ
      Interaction of azimilide with neurohumoral and channel receptors

      BIOCHEMICAL PHARMACOLOGY
    6. Houltz, B; Darpo, B; Swedberg, K; Blomstrom, P; Crijns, HJGM; Jensen, SM; Svernhage, E; Edvardsson, N
      Comparison of QT dispersion during atrial fibrillation and sinus rhythm inthe same patients, at normal and prolonged ventricular repolarization

      EUROPACE
    7. Pool, PE; Singh, SN; Friedrich, T
      Effects of intravenous dofetilide in patients with frequent premature ventricular contractions: A clinical trial

      CLINICAL CARDIOLOGY
    8. Virag, L; Fazekas, T; Iost, N; Varro, A; Berlin, KD; Scherlag, BJ; Lazzara, R; Papp, JG
      Effect of GLG-V-13, a Class III antiarrhythmic agent, on potassium currents in rabbit ventricular myocytes

      LIFE SCIENCES
    9. Sato, N; Tanaka, H; Habuchi, Y; Giles, WR
      Electrophysiological effects of ibutilide on the delayed rectifier K+ current in rabbit sinoatrial and atrioventricular node cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    10. Ravens, U; Wettwer, E
      Electrophysiological aspects of changes in heart rate

      HEART RATE AS A DETERMINANT OF CARDIAC FUNCTION
    11. Weirich, J; Antoni, H
      Rate-dependence of antiarrhythmic and proarrhythmic properties of class I and class III antiarrhythmic drugs

      HEART RATE AS A DETERMINANT OF CARDIAC FUNCTION
    12. Qi, XQ; Newman, D; Dorian, P
      Azimilide decreases defibrillation voltage requirements and increases spatial organization during ventricular fibrillation

      JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
    13. Houltz, B; Darpo, B; Swedberg, K; Blomstrom, P; Brachmann, J; Crijns, HJGM; Jensen, SM; Svernhage, E; Vallin, H; Edvardsson, N
      Effects of the I-kr-blocker almokalant and predictors of conversion of chronic atrial tachyarrhythmias to sinus rhythm. A prospective study

      CARDIOVASCULAR DRUGS AND THERAPY
    14. Corey, A; Al-Khalidi, H; Brezovic, C; Marcello, S; Parekh, N; Taylor, K; Karam, R
      Azimilide pharmacokinetics and pharmacodynamics upon multiple oral dosing

      BIOPHARMACEUTICS & DRUG DISPOSITION
    15. Kiehn, J; Thomas, D; Karle, CA; Schols, W; Kubler, W
      Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    16. Fedorov, VV; Sharifov, OF; Rosenshtraukh, LV; Beloshapko, GG; Yushmanova, AV
      Mechanism of antiarrhythmic action of nibentan on experimental model of vagotonic atrial fibrillation in the canine heart

      KARDIOLOGIYA
    17. Kondo, M; Tsutsumi, T; Mashima, S
      Potassium channel openers antagonize the effects of class III antiarrhythmic agents in canine purkinje fiber action potentials - Implications for prevention of proarrhythmia induced by class III agents

      JAPANESE HEART JOURNAL
    18. Malecot, CO; Argibay, JA
      Block of gating currents related to K+ channels as a mechanism of action of clofilium and d-sotalol in isolated guinea-pig ventricular heart cells

      BRITISH JOURNAL OF PHARMACOLOGY
    19. SPENCE S; SOPER K; HOE CM; COLEMAN J
      THE HEART RATE-CORRECTED QT INTERVAL OF CONSCIOUS BEAGLE DOGS - A FORMULA BASED ON ANALYSIS OF COVARIANCE

      TOXICOLOGICAL SCIENCES
    20. RAVENS U; WETTWER E
      ELECTROPHYSIOLOGICAL ASPECTS OF CHANGES IN HEART-RATE

      Basic research in cardiology
    21. WEIRICH J; ANTONI H
      RATE-DEPENDENCE OF ANTIARRHYTHMIC AND PROARRHYTHMIC PROPERTIES OF CLASS-I AND CLASS-III ANTIARRHYTHMIC DRUGS

      Basic research in cardiology
    22. RITCHIE RH; SALLUSTIO BC; HII JTY; HOROWITZ JD
      SHORT-TERM MYOCARDIAL UPTAKE OF D-SOTALOL AND L-SOTALOL IN HUMANS - RELATION TO HEMODYNAMIC AND ELECTROPHYSIOLOGIC EFFECTS

      Journal of cardiovascular pharmacology
    23. LEE KH; LEE JY; KIM HY; KWON LS; SHIN HS; TANABE S; KOZONO T; PARK SD; CHUNG YS
      KCB-328 - A NOVEL CLASS-III ANTIARRHYTHMIC AGENT WITH LITTLE REVERSE FREQUENCY-DEPENDENCE IN ISOLATED GUINEA-PIG MYOCARDIUM

      Journal of cardiovascular pharmacology
    24. FRIEDRICHS GS; ABREU JN; DRISCOLL EM; BORLAK J; LUCCHESI BR
      ANTIFIBRILLATORY EFFICACY OF LONG-TERM TEDISAMIL ADMINISTRATION IN A POSTINFARCTED CANINE MODEL OF ISCHEMIC VENTRICULAR-FIBRILLATION

      Journal of cardiovascular pharmacology
    25. PARIKKA H; TOIVONEN L; HEIKKILA L; VIRTANEN K; JARVINEN A
      COMPARISON OF SOTALOL AND METOPROLOL IN THE PREVENTION OF ATRIAL-FIBRILLATION AFTER CORONARY-ARTERY BYPASS-SURGERY

      Journal of cardiovascular pharmacology
    26. GEONZON R; EXNER DV; WOODMAN RC; WANG L; FENG ZP; DUFF HJ
      A HIGH-AFFINITY BINDING-SITE FOR [H-3]-DOFETILIDE ON HUMAN-LEUKOCYTES

      Journal of Molecular and Cellular Cardiology
    27. TAKATSUKI S; MITAMURA H; SUEYOSHI K; KANKI H; FURUNO I; OGAWA S
      DISCORDANT PROLONGATION OF THE REFRACTORY PERIOD AND REPOLARIZATION TIME BY A CLASS-III AGENT, E4031, IN THE HEALING PHASE OF MYOCARDIAL-INFARCTION

      Japanese Heart Journal
    28. NAITOH N; TANEDA K; TAGAWA M; FURUSHIMA H; YAMAURA M; AIZAWA Y
      ELECTROPHYSIOLOGIC EFFECTS OF INTRAVENOUS MS-551, A NOVEL CLASS-III ANTIARRHYTHMIC AGENT, ON HUMAN ATRIUM AND VENTRICLE

      Japanese Heart Journal
    29. NAITOH N; WASHIZUKA T; TAKAHASHI K; MIYAJIMA T; AIZAWA Y
      COMPARATIVE ELECTROPHYSIOLOGIC FINDINGS BETWEEN RESPONDERS AND NONRESPONDERS TO CLASS-III ANTIARRHYTHMIC DRUGS AMONG PATIENTS WITH VENTRICULAR TACHYARRHYTHMIA

      Japanese Heart Journal
    30. BRIL A; FOREST MC; CHEVAL B; FAIVRE JF
      COMBINED POTASSIUM AND CALCIUM-CHANNEL ANTAGONISTIC ACTIVITIES AS A BASIS FOR NEUTRAL FREQUENCY-DEPENDENT INCREASE IN ACTION-POTENTIAL DURATION - COMPARISON BETWEEN BRL-32872 AND AZIMILIDE

      Cardiovascular Research
    31. XUE YX; YAMADA C; AYE NN; HASHIMOTO K
      MS-551 AND KCB-328, 2 CLASS-III DRUGS AGGRAVATED ADRENALINE-INDUCED ARRHYTHMIAS

      British Journal of Pharmacology
    32. PATTERSON E; SCHERLAG BJ; LAZZARA R
      EARLY AFTERDEPOLARIZATIONS PRODUCED BY D,L-SOTALOL AND CLOFILIUM

      Journal of cardiovascular electrophysiology
    33. GROH WJ; GIBSON KJ; MAYLIE JG
      COMPARISON OF THE RATE-DEPENDENT PROPERTIES OF THE CLASS-III ANTIARRHYTHMIC AGENTS AZIMILIDE (NE-10064) AND E-4031 - CONSIDERATIONS ON THE MECHANISM OF REVERSE RATE-DEPENDENT ACTION-POTENTIAL PROLONGATION

      Journal of cardiovascular electrophysiology
    34. YAO JA; TSENG GN
      AZIMILIDE (NE-10064) CAN PROLONG OR SHORTEN THE ACTION-POTENTIAL DURATION IN CANINE VENTRICULAR MYOCYTES - DEPENDENCE ON BLOCKADE OF K, CA,AND NA CHANNELS

      Journal of cardiovascular electrophysiology
    35. SCHREIECK J; WANG YG; GJINI V; KORTH M; ZRENNER B; SCHOMIG A; SCHMITT C
      DIFFERENTIAL EFFECT OF BETA-ADRENERGIC STIMULATION ON THE FREQUENCY-DEPENDENT ELECTROPHYSIOLOGIC ACTIONS OF THE NEW CLASS-III ANTIARRHYTHMICS DOFETILIDE, AMBASILIDE, AND CHROMANOL 293B

      Journal of cardiovascular electrophysiology
    36. MITTELSTADT SW; MAYNARD AE; BENN DR; LOWE ER; KOSTREVA DR
      EFFECTS OF AZIMILIDE AND D,L-SOTALOL ON THE HEART-RATE AND BLOOD-PRESSURE RESPONSE TO ISOPROTERENOL IN ANESTHETIZED RATS

      Cardiovascular drugs and therapy
    37. NAIR LA; GRANT AO
      EMERGING CLASS-III ANTIARRHYTHMIC AGENTS - MECHANISM OF ACTION AND PROARRHYTHMIC POTENTIAL

      Cardiovascular drugs and therapy
    38. WILLIAMS BA; BEATCH GN
      MAGNESIUM SHIFTS VOLTAGE-DEPENDENCE OF ACTIVATION OF DELAYED RECTIFIER I-K IN GUINEA-PIG VENTRICULAR MYOCYTES

      American journal of physiology. Heart and circulatory physiology
    39. SINGH BN
      AMIODARONE - THE EXPANDING ANTIARRHYTHMIC ROLE AND HOW TO FOLLOW A PATIENT ON CHRONIC THERAPY

      Clinical cardiology
    40. MERKULOVA IN; TARARAK AE; KOTKIN KL; GILITSIN SP; ROSENSHTRAUKH LV; RUDA MY; CHAZOV EI
      CLINICAL-STUDY OF NIBENTAN - NEW CLASS-II I ANTIARRHYTHMIC DRUG .3. EFFICACY IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS - ARRHYTHMOGENIC EFFECTS

      Kardiologia
    41. BOGDANOV KY; VINOGRADOVA TM; ROSENSHTRAUKH LV
      NIBENTAN INHIBITS THE DELAYED RECTIFIER P OTASSIUM CURRENT IN RAT VENTRICULAR MYOCYTES

      Kardiologia
    42. BHATTACHARYYA ML; SARKER S; MULL KP; DEBNAM Q
      CLOFILIUM-INDUCED BLOCK OF DELAYED RECTIFIER TYPE K-CELLS (AT-1 CELLS)( CURRENT IN ATRIAL TUMOR)

      Journal of Molecular and Cellular Cardiology
    43. PATEL RN; HANSON RL; BANERJEE A; SZARKA LJ
      BIOCATALYTIC SYNTHESIS OF SOME CHIRAL DRUG INTERMEDIATES BY OXIDOREDUCTASES

      Journal of the American Oil Chemists' Society
    44. RESTIVO M; HEGAZY M; CAREF EB; AVITABLE MJ; ASSADI MA; ELHAMAMI M; YIN H; PIRACHA M; BROOKS RR; ELSHERIF N
      EFFECTS OF AZIMILIDE DIHYDROCHLORIDE ON CIRCUS MOVEMENT ATRIAL-FLUTTER IN THE CANINE STERILE PERICARDITIS MODEL

      Journal of cardiovascular electrophysiology
    45. ABRAHAMSSON C; CARLSSON L; DUKER G
      LIDOCAINE AND NISOLDIPINE ATTENUATE ALMAKOLANT-INDUCED DISPERSION OF REPOLARIZATION AND EARLY AFTERDEPOLARIZATIONS IN-VITRO

      Journal of cardiovascular electrophysiology
    46. CHEMNITIUS JM; SCHAHMIRZADI F; GONSKA BD; KREUZER H; ZECH R
      INDIRECT PARASYMPATHOMIMETIC ACTIVITY OF THE CLASS-III ANTIARRHYTHMICSUBSTANCE D L-SOTALOL IN-VITRO - REVERSIBLE INHIBITION OF CHOLINESTERASE ISOENZYMES FROM BLOOD AND THE HUMAN CENTRAL-NERVOUS-SYSTEM/

      Pharmacological research
    47. DARPO B; ALMGREN O; BERGSTRAND R; FRANZEN S; EDVARDSSON N
      ASSESSMENT OF FREQUENCY DEPENDENCY OF THE CLASS-III EFFECTS OF ALMOKALANT - A STUDY USING PROGRAMMED STIMULATION AND RECORDING OF MONOPHASIC ACTION-POTENTIALS AND VENTRICULAR PACED QT INTERVALS

      Cardiovascular drugs and therapy
    48. GROVER GJ; DALONZO AJ; DZWONCZYK S; PARHAM CS; DARBENZIO RB
      PRECONDITIONING IS NOT ABOLISHED BY THE DELAYED RECTIFIER K+ BLOCKER DOFETILIDE

      American journal of physiology. Heart and circulatory physiology
    49. SUN XD; HERNESS MS
      INHIBITION OF POTASSIUM CURRENTS BY THE ANTIARRHYTHMIC DRUG E4031 IN RAT TASTE RECEPTOR-CELLS

      Neuroscience letters
    50. DAI DZ; YU F; LI HT; TANG YQ; AN LF; HUANG WL; PENG SX; HAO XM; ZHOU BA; HU CH
      BLOCKADE ON SODIUM, POTASSIUM, AND CALCIUM CHANNELS BY A NEW ANTIARRHYTHMIC AGENT CPU-86017

      Drug development research
    51. HEWETT KW; LE FK; MARTIN KL; BRASINGTON CR; PIECUCH S; CASE CL
      CHANGES IN ATRIOVENTRICULAR-CONDUCTION PROPERTIES WITH REFRACTORY-PERIOD MODULATION

      Journal of cardiovascular pharmacology
    52. BEATCH GN; DICKENSON YR; WOOD RH; TANG ASL
      CLASS-III ANTIARRHYTHMIC EFFECTS OF LY-190147 ON DEFIBRILLATION THRESHOLD

      Journal of cardiovascular pharmacology
    53. YAMADA A; MOTOMURA S; HASHIMOTO K
      COMPARISON OF DIRECT NEGATIVE CHRONOTROPIC AND POSITIVE INOTROPIC EFFECTS OF SEMATILIDE TO THOSE OF E-4031 AND MS-551 AND THE REVERSE FREQUENCY-DEPENDENT PROLONGATION OF CARDIAC REFRACTORINESS OF SEMATILIDE

      Journal of cardiovascular pharmacology
    54. TUININGA YS; DELANGEN CDJ; CRIJNS HJGM; WIESFELD ACP; MOOK PH; BEL KJ; LIE KI
      ELECTROPHYSIOLOGICAL, RATE-DEPENDENT, AND AUTONOMIC EFFECTS OF THE CLASS-III ANTIARRHYTHMIC ALMOKALANT AFTER MYOCARDIAL-INFARCTION IN THE PIG

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    55. KURUMA A; ATARASHI H; INO T; YASHIMA M; NOMURA A; HAYAKAWA H
      USE OF INTRAVENOUS DOFETILIDE IN ATRIAL-FLUTTER WITH HEMODYNAMIC INSTABILITY

      Japanese Circulation Journal
    56. KOIDL B; FLASCHBERGER P; SCHAFFER P; PELZMANN B; BERNHART E; MACHLER H; RIGLER B
      EFFECTS OF THE CLASS-III ANTIARRHYTHMIC DRUG AMBASILIDE ON OUTWARD CURRENTS IN HUMAN ATRIAL MYOCYTES

      Naunyn-Schmiedeberg's archives of pharmacology
    57. RUDA MY; MERKULOVA IN; TARARAK AE; DRAGNEV AG; GOLITSIN SP; ROSENSHTRAUKH LV; CHAZOV EI
      CLINICAL-STUDY OF NIBENTAN - NEW CLASS-II I ANTIARRHYTHMIC DRUG .2. EFFICACY IN PATIENTS WITH SUPRAVENTRICULAR ARRHYTHMIAS

      Kardiologia
    58. MAYKOV EB; BAKALOV SA; KRUTANOV IB; GOLITSIN SP; RUDA MY; ROSENSHTRAUKH LV; CHAZOV EI
      ELECTROPHYSIOLOGICAL AND ANTIARRHYTHMIC E FFECTS OF A NEW CLASS-III ANTIARRHYTHMIC DRUG NIBENTAN IN PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYARRHYTHMIAS

      Kardiologia
    59. FISET C; FENG ZP; WANG L; SHELDON RS; DUFF HJ
      [H-3] DOFETILIDE BINDING - BIOLOGICAL MODELS THAT MANIFEST SOLELY THEHIGH OR THE LAW AFFINITY BINDING-SITE

      Journal of Molecular and Cellular Cardiology
    60. SPECTOR PS; CURRAN ME; KEATING MT; SANGUINETTI MC
      CLASS-III ANTIARRHYTHMIC DRUGS BLOCK HERG, A HUMAN CARDIAC DELAYED RECTIFIER K- OPEN-CHANNEL BLOCK BY METHANESULFONANILIDES( CHANNEL )

      Circulation research
    61. CHEN JG; KOMORI S; LI BH; TAMURA K; HASHIMOTO K
      I-K INDEPENDENT CLASS-III ACTIONS OF MS-551 COMPARED WITH SEMATILIDE AND DOFETILIDE DURING REPERFUSION IN ANESTHETIZED RATS

      British Journal of Pharmacology
    62. MORI K; SAITO T; MASUDA Y; NAKAYA H
      EFFECTS OF CLASS-III ANTIARRHYTHMIC DRUGS ON THE NA-ACTIVATED K+ CHANNELS IN GUINEA-PIG VENTRICULAR CELLS()

      British Journal of Pharmacology
    63. PUISIEUX FL; ADAMANTIDIS MM; DUMOTIER BM; DUPUIS BA
      CISAPRIDE-INDUCED PROLONGATION OF CARDIAC ACTION-POTENTIAL AND EARLY AFTERDEPOLARIZATIONS IN RABBIT PURKINJE-FIBERS

      British Journal of Pharmacology
    64. BEATCH GN; DICKENSON DR; TANG ASL
      EFFECTS OF OPTICAL ENANTIOMERS CK-4000(S) AND CK4001(R) ON DEFIBRILLATION AND ENHANCEMENT OF SHOCK-INDUCED EXTENSION OF ACTION-POTENTIAL DURATION

      Journal of cardiovascular electrophysiology
    65. SCHEINMAN MM
      PARENTERAL ANTIARRHYTHMIC DRUG-THERAPY IN VENTRICULAR-TACHYCARDIA VENTRICULAR-FIBRILLATION - EVOLVING ROLE OF CLASS-III AGENTS - FOCUS ON AMIODARONE

      Journal of cardiovascular electrophysiology
    66. HERZER T; WAGNER CA; WALDEGGER S; LANG F; BUSCH AE
      EFFECTS OF CHANNEL MODULATION AND PH ON I-SK INHIBITION BY THE NOVEL CLASS-III ANTIARRHYTHMIC AZIMILIDE(NE-10064)

      European journal of pharmacology. Molecular pharmacology section
    67. ONO K; ITO H
      THE ROLE OF THE DELAYED RECTIFIER K+ CURRENT IN THE PACEMAKER ACTIVITY IN RABBIT SINOATRIAL NODE CELLS

      Heart and vessels
    68. ITO H; ONO K
      A RAPIDLY ACTIVATING DELAYED RECTIFIER K+ CHANNEL IN RABBIT SINOATRIAL NODE CELLS

      American journal of physiology. Heart and circulatory physiology
    69. ONO K; ITO H
      ROLE OF RAPIDLY ACTIVATING DELAYED RECTIFIER K+ CURRENT IN SINOATRIALNODE PACEMAKER ACTIVITY

      American journal of physiology. Heart and circulatory physiology
    70. DALONZO AJ; SEWTER JC; DARBENZIO RB; HESS TA
      EFFECTS OF DOFETILIDE ON ELECTRICAL DISPERSION AND ARRHYTHMIAS IN POST-INFARCTED ANESTHETIZED DOGS

      Basic research in cardiology
    71. ISHII M; KAMIYA J; HASHIMOTO K
      CELLULAR ELECTROPHYSIOLOGICAL EFFECTS OF MS-551, A NEW CLASS-III ANTIARRHYTHMIC AGENT

      Drug development research
    72. DARPO B; VALLIN H; ALMGREN O; BERGSTRAND R; INSULANDER P; EDVARDSSON N
      SELECTIVE I-K BLOCKER ALMOKALANT EXHIBITS CLASS III-SPECIFIC EFFECTS ON THE REPOLARIZATION AND REFRACTORINESS OF THE HUMAN HEART - A STUDY OF HEALTHY-VOLUNTEERS USING RIGHT-VENTRICULAR MONOPHASIC ACTION-POTENTIAL RECORDINGS

      Journal of cardiovascular pharmacology
    73. DARPO B; EDVARDSSON N
      EFFECT OF ALMOKALANT, A SELECTIVE POTASSIUM CHANNEL BLOCKER, ON THE TERMINATION AND INDUCIBILITY OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIAS - A STUDY IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA

      Journal of cardiovascular pharmacology
    74. DARPO B; ALMGREN O; BERGSTRAND R; BAARNHIELM C; GOTTFRIDSSON C; SANDSTEDT B; EDVARDSSON N
      TOLERANCE AND EFFECTS OF ALMOKALANT, A NEW SELECTIVE I-K BLOCKING-AGENT, ON VENTRICULAR REPOLARIZATION AND ON SINOATRIAL AND ATRIOVENTRICULAR NODAL FUNCTION IN THE HEART - A STUDY IN HEALTHY, MALE-VOLUNTEERS UTILIZING TRANSESOPHAGEAL ATRIAL STIMULATION

      Journal of cardiovascular pharmacology
    75. FRIEDRICHS GS; CHI L; GRALINSKI MR; BLACK SC; BASLER GC; MU DX; PEWITT SR; JOHNSON CR; LUCCHESI BR
      MS-551 PROTECTS AGAINST VENTRICULAR-FIBRILLATION IN A CHRONIC CANINE MODEL OF SUDDEN CARDIAC DEATH

      Journal of cardiovascular pharmacology
    76. ISOMOTO S; KONOE A; CENTURION OA; HAYANO M; KAIBARA M; HIRATA T; YANO K
      ELECTROPHYSIOLOGICAL EFFECTS OF MS-551 IN HUMANS - A CLASS-III ANTIARRHYTHMIC AGENT

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    77. UEMURA H; HARA Y; ENDOU M; MORI K; NAKAYA H
      INTERACTION OF CLASS-III ANTIARRHYTHMIC DRUGS WITH MUSCARINIC M(2) AND M(3) RECEPTORS - RADIOLIGAND BINDING AND FUNCTIONAL-STUDIES

      Naunyn-Schmiedeberg's archives of pharmacology
    78. RUDA MY; MERKULOVA IN; TARARAK AE; BLOKHIN AB; GOLITSIN SP; ROSENSHTRAUKH LV; CHAZOV EI
      CLINICAL INVESTIGATION OF A NEW CLASS-III ANTIARRHYTHMIC DRUG NIBENTAN .1. TOLERABILITY STUDY

      Kardiologia
    79. MAYKOV EB; BAKALOV SA; KRUTANOV IB; GOLITSIN SP; RUDA MY; ROSENSHTRAUKH LV; CHAZOV YI
      PILOT EXPERIENCE IN INVESTIGATION OF ELEC TROPHYSIOLOGICAL AND ANTIARRHYTHMIC EFFECTS OF NIBENTAN IN PATIENTS WITH PAROXYSMAL TACHYARRHYTHMIAS

      Kardiologia
    80. ROSENSHTRAUKH LV; ANYUKHOVSKY EP; BELOSHAPKO GG; YUSHMANOVA AV; NESTERENKO VV; BOGDANOV KY; ZAKHAROV SI; GOLOVINA VA; GOLITSIN SP; RUDA MY; CHAZOV YI
      ELECTROPHYSIOLOGICAL ASPECTS OF CARDIAC A CTION OF A NEW ANTIARRHYTHMIC DRUG NIBENTAN (EXPERIMENTAL-STUDY)

      Kardiologia
    81. ISHII Y; MURAKI K; KURIHARA A; IMAIZUMI Y; WATANABE M
      EFFECTS OF SEMATILIDE, A NOVEL CLASS-III ANTIARRHYTHMIC AGENT, ON ACTION-POTENTIAL IN GUINEA-PIG ATRIUM

      Japanese Journal of Pharmacology
    82. HASHIMOTO K; HARUNO A; HIRASAWA A; AWAJI T; XUE YX; WU ZJ
      EFFECTS OF THE NEW CLASS-III ANTIARRHYTHMIC DRUG MS-551 AND D-SOTALOLON CANINE CORONARY LIGATION-REPERFUSION VENTRICULAR ARRHYTHMIAS

      Japanese Journal of Pharmacology
    83. HODEIGE D; HEYNDRICKX JP; CHATELAIN P; MANNING A
      SR-33589, A NEW AMIODARONE-LIKE ANTIARRHYTHMIC AGENT - ANTI-ADRENOCEPTOR ACTIVITY IN ANESTHETIZED AND CONSCIOUS DOGS

      European journal of pharmacology
    84. KIEHN J; WIBLE B; FICKER E; TAGLIALATELA M; BROWN AM
      CLONED HUMAN INWARD RECTIFIER K-III METHANESULFONANILIDES( CHANNEL ASA TARGET FOR CLASS)

      Circulation research
    85. VERHEIJCK EE; VANGINNEKEN ACG; BOURIER J; BOUMAN LN
      EFFECTS OF DELAYED RECTIFIER CURRENT BLOCKADE BY E-4031 ON IMPULSE GENERATION IN SINGLE SINOATRIAL NODAL MYOCYTES OF THE RABBIT

      Circulation research
    86. SAEKI T; NISHIMURA M; FOLLMER CH; WATANABE Y
      SELECTIVE BLOCK OF DELAYED RECTIFYING POTASSIUM CURRENT IN THE RABBITSINOATRIAL NODE BY A NOVEL CLASS-III ANTIARRHYTHMIC AGENT MS-551

      Heart and vessels
    87. GREBER TF; OLAH TV; GILBERT JD; PORRAS AG; HICHENS M
      DETERMINATION OF L-691,121, A NEW CLASS-III ANTIARRHYTHMIC, AND ITS PRINCIPAL METABOLITE IN PLASMA BY DIFFERENTIAL RADIOIMMUNOASSAY

      Journal of pharmaceutical and biomedical analysis
    88. CRIJNS HJGM; VANGELDER IC; KINGMA JH; DUNSELMAN PHJM; GOSSELINK ATM; LIE KI
      ATRIAL-FLUTTER CAN BE TERMINATED BY A CLASS-III ANTIARRHYTHMIC DRUG BUT NOT BY A CLASS-IC DRUG

      European heart journal
    89. BASKIN EP; LYNCH JJ
      COMPARATIVE EFFECTS OF INCREASED EXTRACELLULAR POTASSIUM AND PACING FREQUENCY ON THE CLASS-III ACTIVITIES OF METHANESULFONANILIDE I-KR BLOCKERS DOFETILIDE, D-SOTALOL, E-4031, AND MK-499

      Journal of cardiovascular pharmacology
    90. MCINTOSH MA; TANIRA M; PACINI D; KANE KA
      COMPARISON OF THE CARDIAC ELECTROPHYSIOLOGIC EFFECTS OF NE-10064 WITHSOTALOL AND E-4031 AND THEIR MODIFICATION BY SIMULATED ISCHEMIA

      Journal of cardiovascular pharmacology
    91. KONDOH K; HASHIMOTO H; NISHIYAMA H; UMEMURA K; OZAKI T; UEMATSU T; NAKASHIMA M
      EFFECTS OF MS-551, A NEW CLASS-III ANTIARRHYTHMIC DRUG, ON PROGRAMMEDSTIMULATION-INDUCED VENTRICULAR ARRHYTHMIAS, ELECTROPHYSIOLOGY, AND HEMODYNAMICS IN A CANINE MYOCARDIAL-INFARCTION MODEL

      Journal of cardiovascular pharmacology
    92. FRIEDRICHS GS; CHI LG; BLACK SC; MANLEY PJ; LUCCHESI BR
      ANTIARRHYTHMIC AGENT, MS-551, PROTECTS AGAINST PINACIDIL PLUS HYPOXIA-INDUCED VENTRICULAR-FIBRILLATION IN LANGENDORFF-PERFUSED RABBIT ISOLATED HEART

      Journal of cardiovascular pharmacology
    93. OHLER A; AMOS GJ; WETTWER E; RAVENS U
      FREQUENCY-DEPENDENT EFFECTS OF E-4031, ALMOKALANT, DOFETILIDE AND TEDISAMIL ON ACTION-POTENTIAL DURATION - NO EVIDENCE FOR REVERSE USE-DEPENDENT BLOCK

      Naunyn-Schmiedeberg's archives of pharmacology
    94. BUSCH AE; HERZER T; TAKUMI T; KRIPPEITDREWS P; WALDEGGER S; LANG F
      BLOCKADE OF HUMAN I-SK CHANNELS EXPRESSED IN XENOPUS OOCYTES BY THE NOVEL CLASS-III ANTIARRHYTHMIC NE-10064

      European journal of pharmacology
    95. ZHANG ZH; BOUTJDIR M; ELSHERIF N
      KETANSERIN INHIBITS DEPOLARIZATION-ACTIVATED OUTWARD POTASSIUM CURRENT IN RAT VENTRICULAR MYOCYTES

      Circulation research
    96. FRIEDRICHS GS; CHI LG; GREEN AL; LUCCHESI BR
      ANTIFIBRILLATORY EFFECTS OF CLOFILIUM IN THE RABBIT ISOLATED HEART

      British Journal of Pharmacology
    97. OGAWA S; MITAMURA H; KATOH H
      EFFECT OF E-4031, A NEW CLASS-III ANTIARRHYTHMIC DRUG, ON REENTRANT VENTRICULAR ARRHYTHMIAS - COMPARISON WITH CONVENTIONAL CLASS-I DRUGS

      Cardiovascular drugs and therapy
    98. KAMIYA J; ISHII M; YOSHIHARA K; OYABE A; BANNO H; KATAKAMI T
      MS-551 - PHARMACOLOGICAL PROFILE OF A NOVEL CLASS-III ANTIARRHYTHMIC AGENT

      Drug development research
    99. NOVOSEL D; HOF A; ZIERHUT W; HOF RP
      PROARRHYTHMIC EFFECTS OF DPI 201-106 ELICITED WITH PROGRAMMED ELECTRICAL-STIMULATION - A COMPARISON WITH SOTALOL

      Journal of cardiovascular pharmacology
    100. DHEIN S; GERWIN R; ZISKOVEN U; SCHOTT M; RUMP AFE; ZHAO Y; SALAMEH A; KLAUS W
      PROPRANOLOL UNMASKS CLASS-III LIKE ELECTROPHYSIOLOGICAL PROPERTIES OFNOREPINEPHRINE

      Naunyn-Schmiedeberg's archives of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/01/21 alle ore 22:13:52